Sana Biotechnology is a clinical-stage biotechnology company (NASDAQ: SANA) focused on engineering cells as medicines. Its platforms repair or control genes inside cells and replace missing or damaged cells to address the underlying causes of disease, with drug candidates spanning type 1 diabetes, B-cell cancers, and B-cell-mediated autoimmune… - View it on GitHub